The NYT Connections has quickly become a favorite among puzzle enthusiasts worldwide.

In its 'Regulations relating to Professional Conduct of Registered Medical Practitioners" issued on August 2, the NMC stated that over-the-...

Mediterranean diet includes lots of fruit, vegetables, nuts, whole grains, fish, and healthy oils.

Itchy eyes related problems can be triggered by exposure to pollen, animal fur, mould, dust mites, make-up, or eye drops. The body reacts t...

Glenmark will receive an upfront payment as well as regulatory and sales-based milestone payments from Lotus, it added.

Stress can interact with immune cells and regulate how they respond to allergens, causing physical symptoms and disease.

The company had posted a net profit of Rs 223.58 crore for the corresponding period of the previous fiscal, Glenmark Pharmaceuticals said i...

Allergic rhinitis is of two types: seasonal and perennial.

"USFDA has granted approval for an abbreviated new drug application (ANDA) for loratadine liquid filled capsules 10 mg", Marksans Pharma sa...

The list includes 50 varieties of fishes including Indian scad, Talang queenfish, Atlantic Horse Mackerel, Bonga Shad, Spearfish, Skipjack ...

Jubilant Life Sciences had a total of 781 filings for formulations of which 333 have been approved in various regions globally as on Decemb...

Sun Pharma Advanced Research Company today said it has received the approval of the DGCI for its medicine for treatment of breast cancer.

The government today said it has cleared 14 FDI proposals worth Rs 113.35 crore including three from the pharmaceutical sector.

The Drug Controller General of India (DCGI) is planning a survey to detect the quantum of spurious and substandard drugs being sold to unsu...

Bangalore-based pharma company Bal Pharma is planning to raise $20 million for capacity expansion and asset acquisition.

Mid-sized pharma company Indoco Remedies plans to start manufacturing novel drugs under the novel drug delivery system (NDDS) platform.

Goldman Sachs’ private equity fund has bought 7% in Fulford India, an affiliate of the US-based pharma firm, Schering-Plough, for Rs 13 cro...